We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Cutaneous sarcoidosis developing after treatment with pegylated interferon and ribavirin: a new case and review of the literature.
- Authors
López, Verónica; Molina, Inmaculada; Monteagudo, Carlos; Jordá, Esperanza
- Abstract
Sarcoidosis is a multisystem granulomatous disease that affects multiple organs in adults between 20 and 50 years old. Interferon alpha (IFN-α) is an immunomodulator that has been used in a wide range of diseases, including hepatitis C virus infection, multiple sclerosis, and other types of neoplasias, including leukemia, lymphoma, Kaposi's sarcoma, and melanoma. Standard IFN-α-induced sarcoidosis has been reported, but there are few reports of cutaneous sarcoidosis with pegylated IFN-α therapy. We present a new case of cutaneous sarcoidosis after treatment with pegylated IFN, and a review of the literature.
- Subjects
CASE studies; SARCOIDOSIS; IMMUNOLOGICAL adjuvants; LYMPHOMAS; HEPATITIS C treatment; MULTIPLE sclerosis treatment
- Publication
International Journal of Dermatology, 2011, Vol 50, Issue 3, p287
- ISSN
0011-9059
- Publication type
Article
- DOI
10.1111/j.1365-4632.2010.04728.x